122 related articles for article (PubMed ID: 18931719)
1. [Inhibition of cardiac hypertrophy by mitofusin 2 in neonatal rat cardiomyocytes].
Chen CL; Shen T; Zheng M; Guo YH; Zhu XJ; Chen GH
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):528-32. PubMed ID: 18931719
[TBL] [Abstract][Full Text] [Related]
2. MiR-485-5p modulates mitochondrial fission through targeting mitochondrial anchored protein ligase in cardiac hypertrophy.
Zhao Y; Ponnusamy M; Liu C; Tian J; Dong Y; Gao J; Wang C; Zhang Y; Zhang L; Wang K; Li P
Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2871-2881. PubMed ID: 28782654
[TBL] [Abstract][Full Text] [Related]
3. Mitofusin 2 inhibits angiotensin II-induced myocardial hypertrophy.
Yu H; Guo Y; Mi L; Wang X; Li L; Gao W
J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):205-11. PubMed ID: 21106870
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
Xu X; Su YL; Shi JY; Lu Q; Chen C
Cardiovasc Toxicol; 2021 Sep; 21(9):759-771. PubMed ID: 34120306
[TBL] [Abstract][Full Text] [Related]
5. Miro1 as a novel regulator of hypertrophy in neonatal rat cardiomyocytes.
Conejeros C; Parra V; Sanchez G; Pedrozo Z; Olmedo I
J Mol Cell Cardiol; 2020 Apr; 141():65-69. PubMed ID: 32234389
[TBL] [Abstract][Full Text] [Related]
6. [Effect of miRNA-199a on rat cardiac hypertrophy].
Xu XD; Song XW; Jing Q; Qin YW
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 May; 39(5):446-50. PubMed ID: 21781601
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo.
Fang L; Moore XL; Gao XM; Dart AM; Lim YL; Du XJ
Life Sci; 2007 May; 80(23):2154-2160. PubMed ID: 17499311
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
Planavila A; Rodríguez-Calvo R; Jové M; Michalik L; Wahli W; Laguna JC; Vázquez-Carrera M
Cardiovasc Res; 2005 Mar; 65(4):832-41. PubMed ID: 15721863
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-induced cardiomyocyte apoptosis: Role of mitofusin 2.
Tang H; Tao A; Song J; Liu Q; Wang H; Rui T
Int J Biochem Cell Biol; 2017 Jul; 88():55-59. PubMed ID: 28483668
[TBL] [Abstract][Full Text] [Related]
10. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
[TBL] [Abstract][Full Text] [Related]
11. miR-106a promotes cardiac hypertrophy by targeting mitofusin 2.
Guan X; Wang L; Liu Z; Guo X; Jiang Y; Lu Y; Peng Y; Liu T; Yang B; Shan H; Zhang Y; Xu C
J Mol Cell Cardiol; 2016 Oct; 99():207-217. PubMed ID: 27565029
[TBL] [Abstract][Full Text] [Related]
12. Indoxyl sulfate induces oxidative stress and hypertrophy in cardiomyocytes by inhibiting the AMPK/UCP2 signaling pathway.
Yang K; Xu X; Nie L; Xiao T; Guan X; He T; Yu Y; Liu L; Huang Y; Zhang J; Zhao J
Toxicol Lett; 2015 Apr; 234(2):110-9. PubMed ID: 25703824
[TBL] [Abstract][Full Text] [Related]
13. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
14. Expression Profile of microRNAs in Hypertrophic Cardiomyopathy and Effects of microRNA-20 in Inducing Cardiomyocyte Hypertrophy Through Regulating Gene
Sun D; Li C; Liu J; Wang Z; Liu Y; Luo C; Chen Y; Wen S
DNA Cell Biol; 2019 Aug; 38(8):796-807. PubMed ID: 31295012
[TBL] [Abstract][Full Text] [Related]
15. [Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A].
Zhou DX; Liang QS; He XX; Zhan CY
Zhongguo Zhong Yao Za Zhi; 2008 Apr; 33(8):936-9. PubMed ID: 18619357
[TBL] [Abstract][Full Text] [Related]
16. Changes of c-fos and c-jun mRNA expression in angiotensin II-induced cardiomyocyte hypertrophy and effects of sodium tanshinone IIA sulfonate.
Zhou D; Liang Q; He X; Zhan C
J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):531-4. PubMed ID: 18846332
[TBL] [Abstract][Full Text] [Related]
17. A simplified protocol for culture of murine neonatal cardiomyocytes on nanoscale keratin coated surfaces.
Jain A; Ravi V; Muhamed J; Chatterjee K; Sundaresan NR
Int J Cardiol; 2017 Apr; 232():160-170. PubMed ID: 28096043
[TBL] [Abstract][Full Text] [Related]
18. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
[TBL] [Abstract][Full Text] [Related]
19. SOX2-mediated inhibition of miR-223 contributes to STIM1 activation in phenylephrine-induced hypertrophic cardiomyocytes.
Zhao ZH; Luo J; Li HX; Wang SH; Li XM
Mol Cell Biochem; 2018 Jun; 443(1-2):47-56. PubMed ID: 29110214
[TBL] [Abstract][Full Text] [Related]
20. Hypertrophy induced KIF5B controls mitochondrial localization and function in neonatal rat cardiomyocytes.
Tigchelaar W; de Jong AM; Bloks VW; van Gilst WH; de Boer RA; Silljé HH
J Mol Cell Cardiol; 2016 Aug; 97():70-81. PubMed ID: 27094714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]